Generation of an Fgf9 conditional null allele

Genesis (United States)

Volumn 44, Issue 3, 2006, Pages 150-154

  Lin, Yongshun ^a   Liu, Guoqin ^b   Wang, Fen ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Cre LoxP; Fibroblast growth factors; Gene targeting; Prostate

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 9;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO DEVELOPMENT; FGF9 GENE; GENE; GENE TARGETING; HOMEOSTASIS; LUNG MALFORMATION; MOUSE; NONHUMAN; NULL ALLELE; PRIORITY JOURNAL; SEX TRANSFORMATION;

ANIMALIA;

EID: 33645762775     PISSN: 1526954X     EISSN: 1526968X     Source Type: Journal    
DOI: 10.1002/gene.20194     Document Type: Article

References (15)

1. Cinaroglu A, Ozmen Y, Ozdemir A, Ozcan F, Ergorul C, Cayirlioglu P, Hicks D, Bugra K. 2005. Expression and possible function of fibroblast growth factor 9 (FGF9) and its cognate receptors FGFR2 and FGFR3 in postnatal and adult retina. J Neurosci Res 79:329-339.
2. Colvin JS, Feldman B, Nadeau JH, Goldfarb M, Ornitz DM. 1999. Genomic organization and embryonic expression of the mouse fibroblast growth factor 9 gene. Dev Dyn 216:72-88.
3. Colvin JS, Green RP, Schmahl J, Capel B, Ornitz DM. 2001a. Male-to-female sex reversal in mice lacking fibroblast growth factor 9. Cell 104:875-889.
4. Colvin JS, White AC, Pratt SJ, Ornitz DM. 2001b. Lung hypoplasia and neonatal death in Fgf9-null mice identify this gene as an essential regulator of lung mesenchyme. Development 128:2095-2106.
5. Giri D, Ropiquet F, Ittmann M. 1999. FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells. J Cell Physiol 180:53-60.
6. Jin C, McKeehan K, Wang F. 2003. Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens. Prostate 57:160-164.
7. Jin C, Wang F, Wu X, Yu C, Luo Y, McKeehan WL. 2004. Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in two-compartment premalignant prostate tumors. Cancer Res 64:4555-4562.
8. Kinkl N, Ruiz J, Vecino E, Frasson M, Sahel J, Hicks D. 2003. Possible involvement of a fibroblast growth factor 9 (FGF9)-FGF receptor-3-mediated pathway in adult pig retinal ganglion cell survival in vitro. Mol Cell Neurosci 23:39-53.
9. Lu MF, Cheng HT, Kern MJ, Potter SS, Tran B, Diekwisch TG, Martin JF. 1999. prx-1 functions cooperatively with another paired-related homeobox gene, prx-2, to maintain cell fates within the craniofacial mesenchyme. Development 126:495-504.
10. McKeehan WL, Wang F, Kan M. 1998. The heparan sulfate-fibroblast growth factor family: diversity of structure and function. Prog Nucleic Acid Res Mol Biol 59:135-176.
11. Trumpp A, Depew MJ, Rubenstein JL, Bishop JM, Martin GR. 1999. Cre-mediated gene inactivation demonstrates that FGF8 is required for cell survival and patterning of the first branchial arch. Genes Dev 13:3136-3148.
12. Tsai SJ, Wu MH, Chen HM, Chuang PC, Wing LY. 2002. Fibroblast growth factor-9 is an endometrial stromal growth factor. Endocrinology 143:2715-2721.
13. Wang F, McKeehan WL. 2003. The fibroblast growth factor (FGF) signaling complex. In: Handbook of cell signaling, 1st ed. New York: Academic/Elsevier Press, p 265-270.
14. Wu X, Jin C, Wang F, Yu C, McKeehan WL. 2003. Stromal cell heterogeneity in fibroblast growth factor-mediated stromal-epithelial cell crosstalk in premalignant prostate tumors. Cancer Res 63:4936-4944.
15. Zhao S, Hung FC, Colvin JS, White A, Dai W, Lovicu FJ, Ornitz DM, Overbeek PA. 2001. Patterning the optic neuroepithelium by FGF signaling and Ras activation. Development 128:5051-5060.